Meyka Pro banner
Cassiopea S.p.A.

Stay Updated with the Latest Cassiopea S.p.A. SKIN.SW News in Real Time

Find SKIN.SW news now at Meyka AI. Stay informed with the latest Cassiopea S.p.A. stocks updates, including price news, market analysis, and expert insights.

SKIN.SWSIX
HealthcareBiotechnology
CHF35.70
CHF3.20(9.85%)
Swiss Market opens in 11h 38m
Victorian Toddler Dies After Petting Zoo E. Coli Infection, September 2
📅 18 days ago

Victorian Toddler Dies After Petting Zoo E. Coli Infection, September 2

Three-year-old dies from E. coli infection contracted at Victorian petting zoo after six weeks in hospital with kidney failure and brain damage.

Read more 12
Australia’s Diphtheria Outbreak Hits 538 Cases, Largest Since 1991
📅 26 days ago

Australia’s Diphtheria Outbreak Hits 538 Cases, Largest Since 1991

Australia records 538 diphtheria cases in 2026, the largest outbreak since national reporting began in 1991. Cases concentrated in Northern Territory and Western Australia among Aboriginal communities.

Read more 12
Australia’s diphtheria outbreak hits 530 cases, largest since 1991
📅 26 days ago

Australia’s diphtheria outbreak hits 530 cases, largest since 1991

Australia records 530 diphtheria cases in largest outbreak since 1991, with cases concentrated in Northern Territory and Western Australia. Health experts warn actual numbers may be higher due to inconsistent testing.

Read more 12
Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12% on August 20
📅 1 month ago

Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12% on August 20

Moderna jumps 177% and Merck rises 12% after their mRNA cancer vaccine meets Phase 3 endpoints for melanoma. The combo reduced cancer recurrence and spread in over 1,100 patients.

Read more 12
Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update
📅 1 month ago

Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update

Moderna jumped 177% to $174.38 after Phase 3 melanoma vaccine trial success with Merck. The mRNA therapy reduced recurrence risk and represents the first approved late-stage cancer vaccine.

Read more 12
Moderna Soars 177% After Melanoma Vaccine Clears Late-Stage Trial on August 19
📅 1 month ago

Moderna Soars 177% After Melanoma Vaccine Clears Late-Stage Trial on August 19

Moderna jumps 177% and Merck gains 12% after their personalized mRNA cancer vaccine met key goals in a Phase 3 melanoma trial, the first positive late-stage result for an mRNA cancer therapy.

Read more 12
Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12%
📅 1 month ago

Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12%

Moderna jumped 177% and Merck rose 12% after announcing the first Phase 3 win for an mRNA cancer vaccine. The personalized treatment reduced melanoma recurrence risk significantly.

Read more 12
Anant Ambani Airlifts Teen With Rare Water Condition to Mumbai Hospital, August 19
📅 1 month ago

Anant Ambani Airlifts Teen With Rare Water Condition to Mumbai Hospital, August 19

Anant Ambani arranges medical airlift for Murshidabad teenager Iqbal, who spent months living in ponds due to rare condition. Boy now in Mumbai hospital for specialist care.

Read more 12
Squishy Toys Spark Global Safety Crisis: Benzene, Burns, and Recalls on August 18
📅 1 month ago

Squishy Toys Spark Global Safety Crisis: Benzene, Burns, and Recalls on August 18

Squishy toy craze turns dangerous as authorities worldwide recall counterfeit versions containing benzene and causing severe burns. Thailand seized 20,000 units; UK and US issue warnings.

Read more 12

SKIN.SW News FAQ